FdaApplication

ANDA 218311

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLENMARK PHARMACEUTICALS LTD
application_typeANDA
approval_date2024-04-26

Products (1)

ProductActive ingredientStrengthDosage form
ACETAMINOPHEN AND IBUPROFENACETAMINOPHEN; IBUPROFEN250MG;125MGTABLET;ORAL

1 product